NIH-funded research NIH-funded research

Improving access to HIV prevention for young women selling sex in Zimbabwe

Official title: Pharmacy-based PrEP for Young Women who Sell Sex in Zimbabwe

Funded at Centre/sexual Hlth/hiv Aid Res/zimbabwe · NIH-10704134 · Data updated 2026-11-12

This study is working to make it easier for young women who sell sex in Zimbabwe to get and keep using PrEP, a medication that helps prevent HIV, by providing them with personalized support to overcome challenges like stigma and lack of resources.

More PrEP research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCentre/sexual Hlth/hiv Aid Res/zimbabwe
NIH-funded
Lab location1 site (Harare, Zimbabwe)
Project startSeptember 13, 2022
Project endJuly 31, 2025
Funding year2023
Award (this year)$272,655
NIH project number5R34MH129220-02
Project IDNIH-10704134 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are young women aged 21 and older who are engaged in sex work in Zimbabwe.

Less likely to help

Patients who are not involved in sex work or are outside the age range may not benefit from this research.

What this research studies

This research focuses on enhancing access to pre-exposure prophylaxis (PrEP) for young women who sell sex in Zimbabwe, a group at high risk for HIV infection. The project aims to develop and evaluate a pharmacy-based intervention that addresses barriers to PrEP continuation, such as stigma and lack of support. By leveraging psychosocial support and behavioral economics, the study seeks to improve the uptake and sustained use of PrEP among these women. Participants will receive tailored support to help them navigate challenges related to accessing and adhering to PrEP.

Why it matters

Potential benefit: If successful, this research could significantly reduce HIV incidence among young women who sell sex in Zimbabwe.

How similar studies have gone: Previous research has shown that pharmacy-based interventions can be effective in increasing PrEP uptake and adherence among high-risk populations.

Where this research is happening

  • Centre/sexual Hlth/hiv Aid Res/zimbabwe
    Harare, Zimbabwe
    Active

Researchers

  • Principal investigator: Sibanda, Euphemia Lindelwe — Centre/sexual Hlth/hiv Aid Res/zimbabwe
  • Study coordinator: Sibanda, Euphemia Lindelwe

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.